Table III.
Lean (n = 9) |
Obese (n = 9) |
Obese + probucol (n = 9) |
|
---|---|---|---|
Intimal area (mm2) | 0.01 ± 0.0 | 0.12 ± 0.01a | 0.05 ± 0.01b |
Medial area (mm2) | 0.13 ± 0.01 | 0.16 ± 0.0a | 0.15 ± 0.01 |
Intima-to-media ratio | 0.08 ± 0.03 | 0.74 ± 0.05a | 0.28 ± 0.06b |
Reendothelialization (%) | 100 ± 0 | 42 ± 8a | 80 ± 13b |
Total intimal cells (number per high powered field) |
ND | 237 ± 13 | 78 ± 28b |
PCNA+-cells in intima | ND | 50 ± 17 | 11 ± 7b |
Probucol (1%, wt/wt) was administered for 4 wk, with carotid balloon injury performed after 2 wk and carotid artery morphometry, reendothelialization, and intimal cell proliferation assessed at the end of the 4-wk intervention as described in Materials and methods. Total and PCNA+ cells were assessed as the number of cells per high power field (average of three fields). Values are mean ± SEM. ND, not detected.
P < 0.05 versus lean.
P < 0.05 versus obese.